Promus Capital »

iShares NASDAQ Biotechnology Index shares owned by Promus Capital

Quarter-by-quarter ownership of iShares NASDAQ Biotechnology Index (IBB) shares owned by Promus Capital from 13F filings

Historical chart of Promus Capital investment in iShares NASDAQ Biotechnology Index

Tip: Access up to 7 years of quarterly data

All positions including iShares NASDAQ Biotechnology Index held by Promus Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares NASDAQ Biotechnology Index by Promus Capital

Quarter filed Position value Share count Share price at filing
2025-09-30 $20k 136 144.37
2025-06-30 $17k 136 126.51
2025-03-31 $17k 136 127.90
2024-12-31 $18k 136 132.21

More positions owned by Promus Capital

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Global Equity (GLOF)
Spdr Series Trust Prtflo S&p500 Gw (SPYG)
Spdr Series Trust Prtflo S&p500 Vl (SPYV)
Ishares Gold Tr Ishares New (IAU)
Ishares Msci Jpn Etf New (EWJ)
Ishares Tr Msci Emg Mkt Etf (EEM)
Vanguard Intl Equity Index F Ftse Europe Etf (VGK)
Ishares Tr Russell 2000 Etf (IWM)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr Gold Tr Gold Shs (GLD)
Vanguard World Inf Tech Etf (VGT)
Visa Com Cl A (V)

View all positions for Promus Capital

Top funds holding iShares NASDAQ Biotechnology Index

Morgan Stanley
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
UBS Group
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Susquehanna International
Commerce Bank N A
Wells Fargo & Company
Royal Bank of Canada
Calamos Advisors
Jane Street
Citadel Advisors
Leucadia National Corporation
Barclays

View all funds holding iShares NASDAQ Biotechnology Index